Quantifying Biomolecular Organisation in Membranes with Brightness-transit Statistics

Overview

Journal Nat Commun

Specialty Biology

Date 2024 Aug 16

PMID 39152104

Authors

Falk Schneider

Pablo F Cespedes

Narain Karedla

Michael L Dustin

Marco Fritzsche

Affiliations

Soon will be listed here.

Abstract

Cells crucially rely on the interactions of biomolecules at their plasma membrane to maintain homeostasis. Yet, a methodology to systematically quantify biomolecular organisation, measuring diffusion dynamics and oligomerisation, represents an unmet need. Here, we introduce the brightness-transit statistics (BTS) method based on fluorescence fluctuation spectroscopy and combine information from brightness and transit times to elucidate biomolecular diffusion and oligomerisation in both cell-free in vitro and in vitro systems incorporating living cells. We validate our approach in silico with computer simulations and experimentally using oligomerisation of EGFP tethered to supported lipid bilayers. We apply our pipeline to study the oligomerisation of CD40 ectodomain in vitro and endogenous CD40 on primary B cells. While we find a potential for CD40 to oligomerize in a concentration or ligand depended manner, we do not observe mobile oligomers on B cells. The BTS method combines sensitive analysis, quantification, and intuitive visualisation of dynamic biomolecular organisation.

References

Sezgin E, Levental I, Mayor S, Eggeling C . The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017; 18(6):361-374. PMC: 5500228. DOI: 10.1038/nrm.2017.16. View

Cutrale F, Rodriguez D, Hortiguela V, Chiu C, Otterstrom J, Mieruszynski S . Using enhanced number and brightness to measure protein oligomerization dynamics in live cells. Nat Protoc. 2019; 14(2):616-638. DOI: 10.1038/s41596-018-0111-9. View

Varma R, Campi G, Yokosuka T, Saito T, Dustin M . T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity. 2006; 25(1):117-27. PMC: 1626533. DOI: 10.1016/j.immuni.2006.04.010. View

Xavier R, Brennan T, Li Q, McCormack C, Seed B . Membrane compartmentation is required for efficient T cell activation. Immunity. 1998; 8(6):723-32. DOI: 10.1016/s1074-7613(00)80577-4. View

Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A . T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 1999; 283(5402):680-2. DOI: 10.1126/science.283.5402.680. View

Colin-York H, Javanmardi Y, Skamrahl M, Kumari S, Chang V, Khuon S . Cytoskeletal Control of Antigen-Dependent T Cell Activation. Cell Rep. 2019; 26(12):3369-3379.e5. PMC: 6426652. DOI: 10.1016/j.celrep.2019.02.074. View

Balint S, Muller S, Fischer R, Kessler B, Harkiolaki M, Valitutti S . Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells. Science. 2020; 368(6493):897-901. PMC: 7116847. DOI: 10.1126/science.aay9207. View

Vonderheide R . CD40 Agonist Antibodies in Cancer Immunotherapy. Annu Rev Med. 2019; 71:47-58. DOI: 10.1146/annurev-med-062518-045435. View

Quezada S, Jarvinen L, Lind E, Noelle R . CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol. 2004; 22:307-28. DOI: 10.1146/annurev.immunol.22.012703.104533. View

10.

Karpusas M, Hsu Y, Wang J, Thompson J, Lederman S, Chess L . 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure. 1995; 3(12):1426. View

11.

An H, Kim Y, Song D, Park B, Kim H, Lee J . Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation. J Biol Chem. 2011; 286(13):11226-35. PMC: 3064178. DOI: 10.1074/jbc.M110.208215. View

12.

Pound J, Challa A, Holder M, Armitage R, Dower S, Fanslow W . Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Int Immunol. 1999; 11(1):11-20. DOI: 10.1093/intimm/11.1.11. View

13.

Yu X, Chan H, Orr C, Dadas O, Booth S, Dahal L . Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies. Cancer Cell. 2018; 33(4):664-675.e4. PMC: 5896247. DOI: 10.1016/j.ccell.2018.02.009. View

14.

Naismith J, Devine T, Brandhuber B, Sprang S . Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J Biol Chem. 1995; 270(22):13303-7. DOI: 10.1074/jbc.270.22.13303. View

15.

Naismith J, Devine T, Kohno T, Sprang S . Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996; 4(11):1251-62. DOI: 10.1016/s0969-2126(96)00134-7. View

16.

Manzo C, Garcia-Parajo M . A review of progress in single particle tracking: from methods to biophysical insights. Rep Prog Phys. 2015; 78(12):124601. DOI: 10.1088/0034-4885/78/12/124601. View

17.

Lagerholm B, Andrade D, Clausen M, Eggeling C . Convergence of lateral dynamic measurements in the plasma membrane of live cells from single particle tracking and STED-FCS. J Phys D Appl Phys. 2017; 50(6):063001. PMC: 5390782. DOI: 10.1088/1361-6463/aa519e. View

18.

Balzarotti F, Eilers Y, Gwosch K, Gynna A, Westphal V, Stefani F . Nanometer resolution imaging and tracking of fluorescent molecules with minimal photon fluxes. Science. 2016; 355(6325):606-612. DOI: 10.1126/science.aak9913. View

19.

Fritzsche M, Charras G . Dissecting protein reaction dynamics in living cells by fluorescence recovery after photobleaching. Nat Protoc. 2015; 10(5):660-80. DOI: 10.1038/nprot.2015.042. View

20.

Digman M, Gratton E . Lessons in fluctuation correlation spectroscopy. Annu Rev Phys Chem. 2011; 62:645-68. PMC: 3576135. DOI: 10.1146/annurev-physchem-032210-103424. View